Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210284041> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W4210284041 endingPage "453" @default.
- W4210284041 startingPage "445" @default.
- W4210284041 abstract "Background: Hepatitis C virus (HCV) infections in the United States have increased in recent years, with the most rapid rise among people who inject drugs (PWIDs). Historically, there have been concerns regarding treatment adherence among PWIDs with HCV infection, leading to undertreatment of this population and increased HCV transmission. Elbasvir (EBR)/grazoprevir (GZR) has demonstrated high rates of virologic cure (sustained virologic response [SVR]) in clinical trials enrolling PWIDs with HCV infection. Objective: To evaluate the real-world effectiveness of EBR/GZR in HCV genotype (GT) 1-infected patients with a diagnosis of opioid use disorder. Methods: A retrospective analysis of electronic medical records from the US Department of Veterans Affairs Corporate Data Warehouse. Adults with chronic HCV GT1 infection, ≥1 prescription for EBR/GZR, and ≥1 clinic visit were included. All patients had ≥1 ICD-9/10 code of opioid use disorder. SVR was the primary outcome. Results: 419 patients were included; 97.1% had a history of any illicit drug use and 40.8% were receiving medication for opioid use disorder (MOUD). SVR was achieved by 96.9% (406/419) of all patients, 97.0% (350/361) of those receiving EBR/GZR for 12 weeks, and 95.3% (163/171) of those receiving MOUD. SVR in patients receiving psychiatric medications ranged from 96.1% (221/230) in those taking antidepressant medications to 98.5% (128/130) in those taking mood stabilizers. Conclusion: In this real-world setting, high rates of virologic cure were achieved in patients with HCV GT1 infection on MOUD receiving EBR/GZR for 12 weeks, including patients with multiple comorbidities and high rate of psychiatric medication use." @default.
- W4210284041 created "2022-02-08" @default.
- W4210284041 creator A5019712754 @default.
- W4210284041 creator A5021208951 @default.
- W4210284041 creator A5027343826 @default.
- W4210284041 creator A5054964075 @default.
- W4210284041 creator A5075525513 @default.
- W4210284041 creator A5086965411 @default.
- W4210284041 date "2022-01-25" @default.
- W4210284041 modified "2023-10-18" @default.
- W4210284041 title "Treatment of hepatitis C virus infection in people with opioid use disorder: a real-world study of elbasvir/grazoprevir in a US Department of Veterans Affairs population" @default.
- W4210284041 cites W1621802947 @default.
- W4210284041 cites W1903580466 @default.
- W4210284041 cites W1908153784 @default.
- W4210284041 cites W2032868886 @default.
- W4210284041 cites W2069532398 @default.
- W4210284041 cites W2094778224 @default.
- W4210284041 cites W2094976273 @default.
- W4210284041 cites W2180161613 @default.
- W4210284041 cites W2467227824 @default.
- W4210284041 cites W2518041763 @default.
- W4210284041 cites W2527946790 @default.
- W4210284041 cites W2535010553 @default.
- W4210284041 cites W2586420967 @default.
- W4210284041 cites W2593329923 @default.
- W4210284041 cites W2748078120 @default.
- W4210284041 cites W2765348434 @default.
- W4210284041 cites W2778170606 @default.
- W4210284041 cites W2793581566 @default.
- W4210284041 cites W2793631939 @default.
- W4210284041 cites W2805919691 @default.
- W4210284041 cites W2919155466 @default.
- W4210284041 cites W2920098565 @default.
- W4210284041 cites W2945583156 @default.
- W4210284041 cites W3085785957 @default.
- W4210284041 doi "https://doi.org/10.1080/00952990.2021.1983821" @default.
- W4210284041 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35077656" @default.
- W4210284041 hasPublicationYear "2022" @default.
- W4210284041 type Work @default.
- W4210284041 citedByCount "1" @default.
- W4210284041 countsByYear W42102840412022 @default.
- W4210284041 crossrefType "journal-article" @default.
- W4210284041 hasAuthorship W4210284041A5019712754 @default.
- W4210284041 hasAuthorship W4210284041A5021208951 @default.
- W4210284041 hasAuthorship W4210284041A5027343826 @default.
- W4210284041 hasAuthorship W4210284041A5054964075 @default.
- W4210284041 hasAuthorship W4210284041A5075525513 @default.
- W4210284041 hasAuthorship W4210284041A5086965411 @default.
- W4210284041 hasConcept C126322002 @default.
- W4210284041 hasConcept C159047783 @default.
- W4210284041 hasConcept C2522874641 @default.
- W4210284041 hasConcept C2775969662 @default.
- W4210284041 hasConcept C2776408679 @default.
- W4210284041 hasConcept C2776455275 @default.
- W4210284041 hasConcept C2908647359 @default.
- W4210284041 hasConcept C71924100 @default.
- W4210284041 hasConcept C99454951 @default.
- W4210284041 hasConceptScore W4210284041C126322002 @default.
- W4210284041 hasConceptScore W4210284041C159047783 @default.
- W4210284041 hasConceptScore W4210284041C2522874641 @default.
- W4210284041 hasConceptScore W4210284041C2775969662 @default.
- W4210284041 hasConceptScore W4210284041C2776408679 @default.
- W4210284041 hasConceptScore W4210284041C2776455275 @default.
- W4210284041 hasConceptScore W4210284041C2908647359 @default.
- W4210284041 hasConceptScore W4210284041C71924100 @default.
- W4210284041 hasConceptScore W4210284041C99454951 @default.
- W4210284041 hasFunder F4320309610 @default.
- W4210284041 hasFunder F4320332932 @default.
- W4210284041 hasIssue "4" @default.
- W4210284041 hasLocation W42102840411 @default.
- W4210284041 hasLocation W42102840412 @default.
- W4210284041 hasOpenAccess W4210284041 @default.
- W4210284041 hasPrimaryLocation W42102840411 @default.
- W4210284041 hasRelatedWork W2011858350 @default.
- W4210284041 hasRelatedWork W2076740888 @default.
- W4210284041 hasRelatedWork W2091863240 @default.
- W4210284041 hasRelatedWork W2160517174 @default.
- W4210284041 hasRelatedWork W2167679466 @default.
- W4210284041 hasRelatedWork W2567444016 @default.
- W4210284041 hasRelatedWork W2888373095 @default.
- W4210284041 hasRelatedWork W2902338584 @default.
- W4210284041 hasRelatedWork W4311557016 @default.
- W4210284041 hasRelatedWork W4319053938 @default.
- W4210284041 hasVolume "48" @default.
- W4210284041 isParatext "false" @default.
- W4210284041 isRetracted "false" @default.
- W4210284041 workType "article" @default.